Sponsored by an educational grant from Pfizer.

References

  1. Intensive Smoking Cessation Intervention Reduces Mortality In High-Risk Smokers With Cardiovascular Disease. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Chest. 2007;131(2):446-452.
  2. Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome. Eisenberg, Mark B. et al. Circulation. 2016;133:21-30.
  3. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Anthenelli, Robert M et al.